BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32786121)

  • 1. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
    Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
    J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
    Sun XX; Chen Y; Su Y; Wang X; Chauhan KM; Liang J; Daniel CJ; Sears RC; Dai MS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):10983-10988. PubMed ID: 30305424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
    Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
    Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
    Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
    Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncovalent structure of SENP1 in complex with SUMO2.
    Ambaye ND
    Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation.
    Shao L; Liu Y; Wang W; Li A; Wan P; Liu W; Shereen MA; Liu F; Zhang W; Tan Q; Wu K; Liu Y; Wu J
    FASEB J; 2020 Jan; 34(1):1497-1515. PubMed ID: 31914638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
    Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
    Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts.
    Yates KE; Korbel GA; Shtutman M; Roninson IB; DiMaio D
    Aging Cell; 2008 Oct; 7(5):609-21. PubMed ID: 18616636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SENP1 participates in Irinotecan resistance in human colon cancer cells.
    Chen MC; Nhan DC; Hsu CH; Wang TF; Li CC; Ho TJ; Mahalakshmi B; Chen MC; Yang LY; Huang CY
    J Cell Biochem; 2021 Oct; 122(10):1277-1294. PubMed ID: 34037277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic Cells Redistribute SUMO1 upon Forced SUMO1 Overexpression.
    Lee A; Zhu Y; Sabo Y; Goff SP
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
    Witty J; Aguilar-Martinez E; Sharrocks AD
    Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The allosteric effect of the upper half of SENP1 contributes to its substrate selectivity for SUMO1 over SUMO2.
    Shi Y; Yasen M; Wang Z; Du T; Ding Y; Li X; Chai Z; Jie C; Ju G; Ji M
    J Biomol Struct Dyn; 2023; 41(21):12372-12386. PubMed ID: 36656084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Situ SUMOylation and DeSUMOylation Assays: Fluorescent Methods to Visualize SUMOylation and DeSUMOylation in Permeabilized Cells.
    Yuasa E; Saitoh H
    Methods Mol Biol; 2016; 1475():151-9. PubMed ID: 27631804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and paralogue specificity of mammalian deSUMOylating enzymes.
    Kolli N; Mikolajczyk J; Drag M; Mukhopadhyay D; Moffatt N; Dasso M; Salvesen G; Wilkinson KD
    Biochem J; 2010 Sep; 430(2):335-44. PubMed ID: 20590526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress.
    Yang Y; Fu W; Chen J; Olashaw N; Zhang X; Nicosia SV; Bhalla K; Bai W
    Nat Cell Biol; 2007 Nov; 9(11):1253-62. PubMed ID: 17934453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Allosteric Effect of SENP1 Q597A Mutation on the Hydrolytic Reaction of SUMO1 via an Integrated Computational Study.
    Ji M; Chai Z; Chen J; Li G; Li Q; Li M; Ding Y; Lu S; Ju G; Hou J
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pli1(PIAS1) SUMO ligase protected by the nuclear pore-associated SUMO protease Ulp1SENP1/2.
    Nie M; Boddy MN
    J Biol Chem; 2015 Sep; 290(37):22678-85. PubMed ID: 26221037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.
    Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J
    Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.